title: Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
abstract: Therapeutic drug monitoring (TDM) is the process by which a patient's dosing regimen is guided by repeated measures of plasma drug concentrations. An enormous challenge with regard to TDM of antiretroviral drugs (ARV) is that the concentration goals can be moving targets. Well-designed prospective studies demonstrating that prospectively altering ARV doses based on TDM leads to virologic success and increased tolerability are needed. Nevertheless, there are specific clinical instances where this experimental intervention should be considered to potentially reduce toxicity and improve therapeutic outcomes.
authors.affiliation: Division of Clinical Pharmacology, University of Colorado Health Science Center, Denver, CO 80262, USA.
authors.forename: Jennifer J
authors.initials: JJ
authors.lastname: Kiser
authors.forename: Peter L
authors.initials: PL
authors.lastname: Anderson
authors.forename: John G
authors.initials: JG
authors.lastname: Gerber
mesh_terms: D000293:Adolescent; D000328:Adult; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000191:economics / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D010349:Patient Compliance; D011446:Prospective Studies
chemical_list: D044966:Anti-Retroviral Agents